ARTICLE | Company News
Cancer Therapeutics CRC, Cancer Research U.K. deal
August 20, 2012 7:00 AM UTC
The research center's commercial arm Cancer Research Technology (CRT) Ltd. exercised an option to sublicense exclusive, worldwide rights to develop and commercialize Cancer Therapeutics' CTx-0294945 a...